Key Quantitative Figures

Financial Results for Quarter Ended June 30, 2026 (Unaudited):

  • Revenue from Operations: ₹233.66 lakh
  • Total Income: ₹233.66 lakh
  • Total Expenses: ₹243.84 lakh
  • Loss before tax: ₹(10.17) lakh
  • Net Loss after tax: ₹(10.17) lakh
  • Earnings Per Share (Basic): ₹(0.01)
  • Earnings Per Share (Diluted): ₹(0.01)
  • Paid-up Equity Share Capital: ₹7,878.81 lakh

Comparative Figures:

  • Net Loss for quarter ended March 31, 2026: ₹(42.05) lakh
  • Net Loss for quarter ended June 30, 2025: ₹(26.29) lakh
  • Net Loss for year ended March 31, 2026: ₹(111.18) lakh

Dates of Action

  • Board Meeting Date: August 4, 2026 (2:30 PM to 5:50 PM)
  • Effective date for director changes: August 5, 2026
  • 35th AGM Scheduled: September 23, 2026 (11:00 AM)

Parties Involved

  • Resigning Director: Mr. Venkata Sandeep Kumar Reddy Tikkavarapu (DIN: 00005573)
  • New Chairman & MD: Mr. Sreedhara Reddy Kanaparthi (DIN: 09608890)
  • Auditor: MGR & CO Chartered Accountants
  • Regulatory Reference: SEBI Master Circular No: SEBI/HO/CFD/PoD2/CIR/P/0155 dated January 30, 2026

Director Changes and Shareholding

Resignation:

  • Mr. Venkata Sandeep Kumar Reddy Tikkavarapu resigned as Chairman and Non-Executive Director effective August 5, 2026
  • Reason: Professional responsibilities and personal reasons
  • Shareholding: 1,70,06,802 shares in the company

Appointment:

  • Mr. Sreedhara Reddy Kanaparthi's designation changed from Whole-time Director to Chairman and Managing Director effective August 5, 2026
  • Term: 3 years (subject to member approval)
  • Profile: Dynamic leader with global network, MBA (1999-2001), 20 years experience using technology to improve human lives
  • Relationship with other directors: None
  • Not debarred from holding director office

Corporate Actions Approved

1. Name Change Proposal: Change from Gayatri BioOrganics Limited to one of several "Ananth" variants (Ananth BioOrganics Limited, Ananth International BioOrganics Limited, Ananth Global BioOrganics Limited, Anantha BioOrganics Limited, Anantha International BioOrganics Limited, Anantha Global BioOrganics Limited) or such other name as may be approved

2. New MOA and AOA: Adoption of new Memorandum and Articles of Association to align with Companies Act, 2013

3. 35th AGM: Approval of 35th Directors Report and notice for 35th Annual General Meeting

Financial Review

The limited review of quarterly financial results was conducted by MGR & CO Chartered Accountants in accordance with Standard on Review Engagement (SRE) 2410. The auditor's report states that nothing has come to their attention that causes them to believe that the financial results contain any material misstatement.